Search Results 61-70 of 9731 for ishitani'
Itacitinib is an experimental drug with an excellent safety record and appears to have activity as a GVHD treatment. A new blood test can identify patients ...
... Ishitani M, Rodeberg D. Primary hyperparathyroidism in pediatric patients. Pediatrics. 2005 Apr; 115 (4):974-80. View PubMed; Mahmud FH, Linglart A, Bastepe M ...
Clinical Data Interchange Standards Consortium.
About this study. Our aim is to analyze changes in global and/or regional myocardial mechanics of the left and right ventricle before and after hemodialysis ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Gibreel WO, Selcen D, Zeidan MM, Ishitani MB, Moir CR, Zarroug AE. Safety and yield of muscle biopsy in pediatric patients in the modern era. J Pediatr Surg ...
About this study. The purpose of this Phase I/IIA, open-label, multi-center trial is to evaluate the safety, immunogenicity and preliminary clinical ...
The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...
The Allergic Diseases Lab of Hirohito Kita, M.D., at Mayo Clinic studies eosinophil biology, chronic sinusitis, environmental allergens, airway exposure to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.